Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-13 11:51:54 UTC |
---|
Update Date | 2022-03-07 02:57:14 UTC |
---|
HMDB ID | HMDB0041990 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Piritramide |
---|
Description | Piritramide (R-3365, trade names Dipidolor, Piridolan, Pirium and others) is a synthetic opioid analgesic with a potency 0.65 to 0.75 times that of morphine. A common starting dose is 15 mg IV, equivalent to 10 mg of morphine hydrochloride. Piritramide is commonly used for the treatment of postoperative pain. Piritramide was discovered at Janssen Pharmaceutica in 1960 and is currently manufactured and distributed within continental Europe and some other places by Janssen-Cilag. Piritramide is a strong opioid and therefore is regulated much the same as morphine in all known jurisdictions. It was never introduced in the United States and is therefore a Schedule I/Narcotic controlled substance. It is listed under international treaties and other laws such as the German Betabungsmittelgesetz, the Austrian Suchtgiftmittelgesetz, the Opium Laws of various other European countries, Canadian controlled substances act, UK Misuse of Drugs Act of 1971, and equivalents elsewhere. Strangely enough, bezitramide, which is not currently marketed in the United States is a Schedule II/Narcotic controlled substance. Piritramide is also known as pirinitramide. Its closest chemical relatives amongst well-known drugs are diphenoxylate (Lomotil) and bezitramide (Burgodin). Piritramide is available in tablets and ampoules of sterile solution for injection by all routes, and is used in Patient Controlled Analgesia units. In addition to PCA, piritramide is most often used in post-operative situations and emergency departments; some of its properties would seem to lend it well to chronic pain control as well. It is one of the longer-lasting opioids and has a plasma half-life of 3 to 12 hours. Piritramide tends to cause less respiratory depression than morphine and can take a while to have full effect especially if taken by mouth. |
---|
Structure | OC(=N)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)N1CCCCC1 InChI=1S/C27H34N4O/c28-22-26(23-10-4-1-5-11-23,24-12-6-2-7-13-24)14-19-30-20-15-27(16-21-30,25(29)32)31-17-8-3-9-18-31/h1-2,4-7,10-13H,3,8-9,14-21H2,(H2,29,32) |
---|
Synonyms | Value | Source |
---|
Dipidolor | Kegg | Pirinitramide | HMDB | Dipydolor | HMDB | Janssen brand OF pirinitramide | HMDB | Piritramid | HMDB |
|
---|
Chemical Formula | C27H34N4O |
---|
Average Molecular Weight | 430.5851 |
---|
Monoisotopic Molecular Weight | 430.27326173 |
---|
IUPAC Name | 1-(3-cyano-3,3-diphenylpropyl)-4-(piperidin-1-yl)piperidine-4-carboximidic acid |
---|
Traditional Name | piritramid |
---|
CAS Registry Number | 302-41-0 |
---|
SMILES | OC(=N)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)N1CCCCC1 |
---|
InChI Identifier | InChI=1S/C27H34N4O/c28-22-26(23-10-4-1-5-11-23,24-12-6-2-7-13-24)14-19-30-20-15-27(16-21-30,25(29)32)31-17-8-3-9-18-31/h1-2,4-7,10-13H,3,8-9,14-21H2,(H2,29,32) |
---|
InChI Key | IHEHEFLXQFOQJO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diphenylacetonitriles. These are cyclic aromatic compounds containing a diphenylacetonitrile moiety, which consists of a diphenylmethane linked to and acetonitrile to form 2,2-diphenylacetonitrile. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Diphenylacetonitriles |
---|
Direct Parent | Diphenylacetonitriles |
---|
Alternative Parents | |
---|
Substituents | - Diphenylacetonitrile
- Diphenylmethane
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Piperidinecarboxamide
- 4-aminopiperidine
- Aralkylamine
- Piperidine
- Amino acid or derivatives
- Carboxamide group
- Primary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Nitrile
- Carbonitrile
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Amine
- Organic nitrogen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 149.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 3.91 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Piritramide,1TMS,isomer #1 | C[Si](C)(C)OC(=N)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3360.1 | Semi standard non polar | 33892256 | Piritramide,1TMS,isomer #2 | C[Si](C)(C)N=C(O)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3408.1 | Semi standard non polar | 33892256 | Piritramide,2TMS,isomer #1 | C[Si](C)(C)N=C(O[Si](C)(C)C)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3387.2 | Semi standard non polar | 33892256 | Piritramide,2TMS,isomer #1 | C[Si](C)(C)N=C(O[Si](C)(C)C)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3218.5 | Standard non polar | 33892256 | Piritramide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=N)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3595.1 | Semi standard non polar | 33892256 | Piritramide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(O)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3665.1 | Semi standard non polar | 33892256 | Piritramide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3837.9 | Semi standard non polar | 33892256 | Piritramide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)C1(N2CCCCC2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 | 3644.6 | Standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Piritramide GC-MS (Non-derivatized) - 70eV, Positive | splash10-008i-4967000000-98351d91fa44f62e846d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Piritramide GC-MS (1 TMS) - 70eV, Positive | splash10-000i-1229100000-92e9b29f615b196ec03c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Piritramide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 10V, Negative-QTOF | splash10-004i-0001900000-10fa748e1d24c9cc7348 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 20V, Negative-QTOF | splash10-01t9-2554900000-4b8b465687eec62bf59c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 40V, Negative-QTOF | splash10-016u-2910000000-5437b6b34eb661836bf8 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 10V, Negative-QTOF | splash10-004i-0000900000-8a3e205880265040e558 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 20V, Negative-QTOF | splash10-004i-1006900000-a773f591f1b76bda84b0 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 40V, Negative-QTOF | splash10-014l-2692100000-d2863817839d70606d7d | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 10V, Positive-QTOF | splash10-01q9-0013900000-6c90517c14dc6045ba99 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 20V, Positive-QTOF | splash10-00ri-0219100000-558ea112c519bb7157bc | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 40V, Positive-QTOF | splash10-00xr-2963000000-aa8c9a18c6dd4520c39e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 10V, Positive-QTOF | splash10-001i-0002900000-9d7a0fb697bb237c7da7 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 20V, Positive-QTOF | splash10-00kb-0229000000-35840be2b88cda999fd3 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Piritramide 40V, Positive-QTOF | splash10-060u-0925100000-3b5332db3dad544feba2 | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|